Advertisement
Loading...

Liminatus Pharma, Inc. Class A Common Stock

LIMN•NASDAQ
Healthcare
Biotechnology
$0.28
$0.09(46.58%)
U.S. Market is Open • 13:17

Liminatus Pharma, Inc. Class A Common Stock (LIMN) Stock Technical Analysis & Trading Signals

Live technical indicators, trading signals, and momentum insights for Liminatus Pharma, Inc. Class A Common Stock (NASDAQ:LIMN).

Disclaimer for Technical Analysis Page

The technical indicators and trading signals shown on this page are for informational purposes only and do not constitute financial advice. Stock market investments involve risk, and past performance is not a guarantee of future results. Always conduct your own research or consult a licensed financial advisor before making investment decisions.Read our Full Disclaimer

LIMN Technical Analysis Summary

Liminatus Pharma, Inc. Class A Common Stock stock currently trades in a neutral range, with no clear dominance from buyers or sellers.

Overall Sentiment:Neutral
Momentum:Neutral to Bearish (RSI: 43.55)
Trend Strength:Weak (ADX: 14.78)
Volatility:Medium (ATR: 0.01)
Support/Resistance:$0.18 – $0.22 (Bollinger Bands)

This mix signals that Liminatus Pharma, Inc. Class A Common Stock is trading in a balanced range with no clear breakout yet.

Momentum Indicators

RSI (14): 43.55

Bearish
Below midpoint indicates downward pressure.

Stochastic %K: 24.57

Bearish
Momentum remains weak below midpoint.

Williams %R: -76.59

Bearish
Sellers maintain momentum below neutral.

Rate of Change (ROC): -8.04

Strongly Bearish
Sharp downside momentum.

Takeaway:Liminatus Pharma, Inc. Class A Common Stock shows weakening momentum, with sellers gaining the edge.

Trend & Volatility

MACD: 0.00

Neutral
Neutral, momentum shows no clear direction.

ADX: 14.78

Weak
Weak trend, market trading sideways.

ATR (14): 0.01

Low
Low volatility, stable price action.

CCI (14): -60.47

Bearish
Bearish, momentum remains under pressure.

Takeaway:Liminatus Pharma, Inc. Class A Common Stock shows a neutral trend, with weak conviction and limited volatility.

Support & Resistance indicators
Bollinger Bands
Upper Band
$0.22
Middle Band (SMA 20)
$0.20
Lower Band
$0.18
Current Position
Above Upper Band

Takeaway:Liminatus Pharma, Inc. Class A Common Stock trades near the upper band, signaling overbought conditions and risk of pullback.

Keltner Channels
Upper Channel
$0.22
Middle Line (EMA 20)
$0.20
Lower Channel
$0.17
Squeeze Status
Squeeze On

Takeaway:Liminatus Pharma, Inc. Class A Common Stock trades near the upper channel, signaling resistance and risk of pullback.

Volume & Money Flow Analysis
On-Balance Volume88.58M
Money Flow Index52.14Neutral, balanced money flows with no clear signal.
Relative Vigor Index40.79Neutral to Bearish, sellers hold a slight edge.

Overall Takeaway:LIMN shows mixed signals in money flow analysis.

Technical Trading Signals Summary
Based on the current technical analysis of Liminatus Pharma, Inc. Class A Common Stock, here are the key trading signals and recommendations:

Bullish Signals

Price trading above middle Bollinger Band → mid-term support intact.

MFI below 80 → room for more buying without overbought risk.

Bearish Signals

Price near upper Bollinger Band → potential resistance and pullback risk.

RVI below 50 → vigor tilted toward sellers.

Overall Recommendation:Technical indicators for Liminatus Pharma, Inc. Class A Common Stock are mixed, suggesting a Hold or wait-and-see approach.

Technical Analysis FAQ